Net income increased 117.3%
Net income changed +117.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Net income changed +117.3% from the comparable as-filed period.
Operating income changed +75.0% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating margin changed +1699 basis points from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Revenue changed +32.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Selling, general & administrative changed -32.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Stock-based compensation changed -28.5% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Cash & equivalents changed -14.8% from the comparable as-filed period.
Research & development changed -4.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.